Hindilerden, F. Et Al. 2017. Rituximab Therapy in Adults with Refractory Symptomatic Immune Thrombocytopenia: Long-Term Follow-Up of 15 Cases. TURKISH JOURNAL OF HEMATOLOGY , vol.34, no.1 , 72-80.

Hindilerden, F., Yonal-Hindilerden, I., Yenerel, M. N., Nalcaci, M., & Diz-Kucukkaya, R., (2017). Rituximab Therapy in Adults with Refractory Symptomatic Immune Thrombocytopenia: Long-Term Follow-Up of 15 Cases. TURKISH JOURNAL OF HEMATOLOGY , vol.34, no.1, 72-80.

Hindilerden, Fehmi Et Al. "Rituximab Therapy in Adults with Refractory Symptomatic Immune Thrombocytopenia: Long-Term Follow-Up of 15 Cases," TURKISH JOURNAL OF HEMATOLOGY , vol.34, no.1, 72-80, 2017

Hindilerden, Fehmi Et Al. "Rituximab Therapy in Adults with Refractory Symptomatic Immune Thrombocytopenia: Long-Term Follow-Up of 15 Cases." TURKISH JOURNAL OF HEMATOLOGY , vol.34, no.1, pp.72-80, 2017

Hindilerden, F. Et Al. (2017) . "Rituximab Therapy in Adults with Refractory Symptomatic Immune Thrombocytopenia: Long-Term Follow-Up of 15 Cases." TURKISH JOURNAL OF HEMATOLOGY , vol.34, no.1, pp.72-80.

@article{article, author={Fehmi Hindilerden Et Al. }, title={Rituximab Therapy in Adults with Refractory Symptomatic Immune Thrombocytopenia: Long-Term Follow-Up of 15 Cases}, journal={TURKISH JOURNAL OF HEMATOLOGY}, year=2017, pages={72-80} }